Cargando…

Comorbidities in ADHD children treated with methylphenidate: a database study

BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular conditions. We assessed MPH treatment prevalence and inciden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kraut, Angela A, Langner, Ingo, Lindemann, Christina, Banaschewski, Tobias, Petermann, Ulrike, Petermann, Franz, Mikolajczyk, Rafael T, Garbe, Edeltraut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544568/ https://www.ncbi.nlm.nih.gov/pubmed/23294623 http://dx.doi.org/10.1186/1471-244X-13-11

Ejemplares similares

The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study
por: Lindemann, Christina, et al.
Publicado: (2017)

Twin and Sibling Studies Using Health Insurance Data: The Example of Attention Deficit/Hyperactivity Disorder (ADHD)
por: Langner, Ingo, et al.
Publicado: (2013)

Regional variation in caesarean deliveries in Germany and its causes
por: Mikolajczyk, Rafael T, et al.
Publicado: (2013)

Regional and temporal variations in coding of hospital diagnoses referring to upper gastrointestinal and oesophageal bleeding in Germany
por: Langner, Ingo, et al.
Publicado: (2011)

Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study
por: Ohlmeier, Christoph, et al.
Publicado: (2015)

Skin picking disorder comorbid with ADHD successfully treated with methylphenidate
por: Bernardes, Camila, et al.
Publicado: (2018)

Incidence of anogenital warts in Germany: a population-based cohort study
por: Kraut, Angela A, et al.
Publicado: (2010)

Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD)
por: Schmidt, Sören, et al.
Publicado: (2009)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
por: Chermá, Maria D., et al.
Publicado: (2016)

Methylphenidate Ameliorates Depressive Comorbidity in ADHD Children without any Modification on Differences in Serum Melatonin Concentration between ADHD Subtypes
por: Cubero-Millán, Isabel, et al.
Publicado: (2014)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches
por: Kim, Jae-Won, et al.
Publicado: (2015)

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
por: Wolff, Nicole, et al.
Publicado: (2016)

Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
por: D’Aiello, Barbara, et al.
Publicado: (2022)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
por: Zammit, Nowell, et al.
Publicado: (2023)

Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions
por: Retz, Wolfgang, et al.
Publicado: (2020)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
por: Ventura, Patrizia, et al.
Publicado: (2022)

Psicología de la confianza /
por: Petermann, Franz
Publicado: (1999)

Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research
por: Reiersen, Angela M.
Publicado: (2018)

STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD
por: Baumeister, Timo-Benjamin, et al.
Publicado: (2016)

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
por: Natsheh, Joman Y., et al.
Publicado: (2015)

Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018)

Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
por: Chuang, Wei-Chen, et al.
Publicado: (2019)

Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
por: Solleveld, Michelle M., et al.
Publicado: (2017)

Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
por: Maia, Carlos R., et al.
Publicado: (2015)

Prediction of sleep side effects following methylphenidate treatment in ADHD youth
por: Yoo, Jae Hyun, et al.
Publicado: (2019)

Structural brain network topology underpinning ADHD and response to methylphenidate treatment
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
por: Chang, Jung-Chi, et al.
Publicado: (2021)

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
por: Fridman, Moshe, et al.
Publicado: (2017)

How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD
por: Buchhorn, Reiner, et al.
Publicado: (2012)

ADHD diagnosis and methylphenidate consumption in children and adolescents: A systematic analysis of health databases in France over the period 2010–2019
por: Ponnou, Sébastien, et al.
Publicado: (2022)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ecpor894s3clgt0nm31r0s6i28